Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Evaluation of a Cardiac Coherence Session to Reducing Patients' Anxiety During a MRI Examination

NCT05893121 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2023-12-08
Last updated
2026-07-16

Condition(s) studied

Anxiety

Investigational drug(s) / intervention(s)

Cardiac coherence sessionInformation note about MRI

Cardiac coherence session: A cardiac coherence session consists of an exercise of six breaths per minute during five minutes.

Information note about MRI: explanatory note about MRI examination

Study summary

The present project aims at conducting a proof of concept study to explore the pertinence of a single session of cardiac coherence, carried out in patients prior to an MRI examination and presenting anxiety in relation to this examination, to reduce their level of anxiety and thus improve the course of the examination.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Person affiliated to or benefiting from a social security scheme; * Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research); * Patient to undergo an MRI examination of the upper half of the body * Patient over 18 years old * Patient with a high level of anxiety (score ≥ 4) in relation to MRI Non-inclusion Criteria: * Patient under legal protection or under another protection regime (guardianship, curatorship). * Sedated or unconscious patient * Patient performing an emergency MRI examination * Patient with a level of French language that does not allow sufficient understanding for the completion of questionnaires Exclusion criteria: \- STAI Y-A score \< 46 (insignificant or low anxiety)

Primary outcome measure(s)

  • Effect of a cardiac coherence session on the anxiety level — 10 minutes
    The anxiety level will be measured by the Y-A form of the Spielberger State-Trait Anxiety Inventory (French version adapted from the "State-Trait Anxiety Inventory" - STAI) in all patients before the MRI examination is performed

Trial sites (1)

FacilityCityRegionStatus
Pierre Paul Riquet Hospital Toulouse France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05893121 on ClinicalTrials.gov ↗ ← All trials in France